Abeer badawy (4 risultati)

Autore: 
Perfeziona con la Ricerca avanzata

Perfeziona la tua ricerca

  • Libri (4)

a

Fascia di prezzo personalizzata (EUR)

a

  • Lingua: Inglese

    Editore: Grin Verlag, 2015

    3656908907 / 9783656908906

    • Brossura

    Da: California Books, Miami, FL, U.S.A.California Books

    Venditore con 4 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 47,06

     Spedizione gratuita 
    Spedito in U.S.A.

    Quantità: Più di 20 disponibili

    Condizione: New.

  • Lingua: Inglese

    Editore: Grin Publishing, 2015

    3656908907 / 9783656908906

    • Brossura

    Da: Mispah books, Redhill, SURRE, Regno UnitoMispah books

    Venditore con 4 stelle
    Contatta il venditore

    Condizione: Usato - Come nuovo

    EUR 113,81

    EUR 29,08 spedizione 
    Spedito da Regno Unito a U.S.A.

    Quantità: 1 disponibili

    paperback. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

  • Lingua: Inglese

    Editore: GRIN Publishing Mrz 2015, 2015

    3656908907 / 9783656908906

    • Brossura
    • Print on Demand

    Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermaniaBuchWeltWeit Ludwig Meier e.K.

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 34,99

    EUR 23,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 2 disponibili

    Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Master's Thesis from the year 2010 in the subject Medicine - Pharmacology, , language: English, abstract: The thalassemias are a heterogeneous group of genetic disorders of haemoglobin synthesis, occurring more frequently in the Mediterranean region, the Indian subcontinent, Southeast Asia, and West Africa .The thalassemias are divided according to their severity into major which is severe and transfusion dependent, intermediate and minor forms of illness. The beta-thalassemias are the most important types of thalassemia because they are so common and usually produce severe anemia in their homozygous and compound heterozygous states (Hillman et al., 2005).In beta-thalassemia major, the neonate is well at birth but develops severe anemia, bone abnormalities, failure to thrive, and life-threatening complications. In many cases, the first signs are pallor, yellow skin and scleras in infants ages 3 to 6 months. Later clinical features, in addition to severe anemia, include splenomegaly or hepatomegaly, with abdominal enlargement, frequent infections, bleeding tendencies (especially toward epistaxis), and anorexia (Fucharoen et al., 2000).Transfusional iron overload is the most important complication of beta-thalassemia and is a major focus of management, which can be prevented by adequate iron chelation. Extensive iron deposits are associated with cardiac hypertrophy and dilatation, degeneration of myocardial fibers (Aessopos et al., 1995; Du et al., 1997).Hepcidin is a 25-amino-acid iron peptide hormone. Initially identified in human plasma and urine as an anti-microbial molecule. Hepcidin is the key regulator of systemic iron homeostasis and a pathogenic factor in anemia of inflammation and hereditary hemochromatosis. Hepcidin inhibits iron influx into plasma from duodenal enterocytes that absorb dietary iron, from macrophages that recycle iron from senescent erythrocytes and from hepatocytes that store iron (Park et al., 2001).Iron-Loading anemias are characterized by ineffective erythropoiesis and increased intestinal iron absorption. Erythrocyte transfusions further exacerbate the iron overload. The development of hepcidin- based diagnostics and therapies for iron-loading anemias may offer more effective approaches to prevent the toxicity associated with iron overload. The most common iron- loading anemias are major forms of beta-thalassemia (Papanikolaou et al., 2005). [.] 136 pp. Englisch. …

  • Lingua: Inglese

    Editore: GRIN Publishing, 2015

    3656908907 / 9783656908906

    • Brossura
    • Print on Demand

    Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 34,99

    EUR 61,04 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 1 disponibili

    Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Master's Thesis from the year 2010 in the subject Medicine - Pharmacology, , language: English, abstract: The thalassemias are a heterogeneous group of genetic disorders of haemoglobin synthesis, occurring more frequently in the Mediterranean region, the Indian subcontinent, Southeast Asia, and West Africa .The thalassemias are divided according to their severity into major which is severe and transfusion dependent, intermediate and minor forms of illness. The beta-thalassemias are the most important types of thalassemia because they are so common and usually produce severe anemia in their homozygous and compound heterozygous states (Hillman et al., 2005).In beta-thalassemia major, the neonate is well at birth but develops severe anemia, bone abnormalities, failure to thrive, and life-threatening complications. In many cases, the first signs are pallor, yellow skin and scleras in infants ages 3 to 6 months. Later clinical features, in addition to severe anemia, include splenomegaly or hepatomegaly, with abdominal enlargement, frequent infections, bleeding tendencies (especially toward epistaxis), and anorexia (Fucharoen et al., 2000).Transfusional iron overload is the most important complication of beta-thalassemia and is a major focus of management, which can be prevented by adequate iron chelation. Extensive iron deposits are associated with cardiac hypertrophy and dilatation, degeneration of myocardial fibers (Aessopos et al., 1995; Du et al., 1997).Hepcidin is a 25-amino-acid iron peptide hormone. Initially identified in human plasma and urine as an anti-microbial molecule. Hepcidin is the key regulator of systemic iron homeostasis and a pathogenic factor in anemia of inflammation and hereditary hemochromatosis. Hepcidin inhibits iron influx into plasma from duodenal enterocytes that absorb dietary iron, from macrophages that recycle iron from senescent erythrocytes and from hepatocytes that store iron (Park et al., 2001).Iron-Loading anemias are characterized by ineffective erythropoiesis and increased intestinal iron absorption. Erythrocyte transfusions further exacerbate the iron overload. The development of hepcidin- based diagnostics and therapies for iron-loading anemias may offer more effective approaches to prevent the toxicity associated with iron overload. The most common iron- loading anemias are major forms of beta-thalassemia (Papanikolaou et al., 2005). [.].…